Rebecca Abram and Joanna Norman present an overview of rare diseases and what FUJIFILM Diosynth Biotechnologies can offer in terms of strategies to expedite workflows, internalize critical reagents, and standardize facilities and equipment. Alongside a discussion on feasibility and candidate screening.